Metformin upregulated and rescued period circadian regulator 2 (PER2) in GBM cell lines, inhibited their growth by inhibiting the silent information regulator 2 (SIRT2)/glucose-6-phosphate dehydrogenase (G6PD) signaling pathway, and hence enhanced their radio sensitivity. Here, G6PD is linked to glioblastoma.